| Literature DB >> 28265562 |
Terence P Scott1, Andre Coetzer1, Anna S Fahrion2, Louis H Nel1.
Abstract
It is evident that rabies continues to be a neglected tropical disease; however, a recent global drive aims to eliminate canine-mediated human rabies by 2030. Global efforts have been vested into creating and developing resources for countries to take ownership of and overcome the challenges that rabies poses. The disconnect between the numbers of rabies cases reported and the numbers estimated by prediction models is clear: the key to understanding the epidemiology and true burden of rabies lies within accurate and timely data; poor and discrepant data undermine its true burden and negate the advocacy efforts needed to curb this lethal disease. In an effort to address these challenges, the Pan-African Rabies Control Network is developing a regional rabies-specific disease surveillance bulletin based on the District Health Information System 2 platform-a web-based, open access health information platform. This bulletin provides a data repository from which specific key indicators, essential to any rabies intervention program, form the basis of data collection. The data are automatically analyzed, providing useful outputs for targeted intervention. Furthermore, in an effort to reduce reporting fatigue, the data submitted, under authority from the respective governments, can automatically be shared with approved international authorities. The implementation of a rabies-specific bulletin will facilitate targeted control efforts and provide measurements of success, while also acting as a basis for advocacy to raise the priority of this neglected disease.Entities:
Keywords: DHIS2; PARACON; bulletin; data; rabies; reporting; surveillance
Year: 2017 PMID: 28265562 PMCID: PMC5316526 DOI: 10.3389/fvets.2017.00018
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Description of and rationale for using initial basic indicators in the Pan-African Rabies Control Network bulletin.
| Indicator | Disaggregation | Description | Rationale | Reporting period |
|---|---|---|---|---|
| Number of bite cases in humans | Age: <5 years, 5–14 years; ≥15 years; unknown age | Number of bite cases reported at a health-care facility, disaggregated by age, sex, and wound category | To determine at-risk populations (children, adults) and the numbers of people who have been potentially exposed to a rabid animal; this indicator influences decisions regarding human vaccine procurement and targeted education. This indicator also excludes snake bites | Annual |
| Doses of human vaccines purchased | None | Number of human vaccines purchased for the country | To determine the number of vaccines available in the country and whether this complies with PEP requirements | Annual |
| Cost per vaccine (US$) | Private sector | Cost per vaccine administered in a government institution (including all associated costs such as doctor’s fees, consumables, etc.) | To determine the costs associated with procurement and administration of vaccine for budgetary purposes and to advocate the allocation of funds toward rabies control efforts | Annual |
| Doses of animal vaccine available | Purchased this year | Number of animal vaccines administered, carried over, and purchased by the government for mass vaccination campaigns | To establish the number of vaccine doses available to the government; this indicator is also used for the eventual calculation of the estimated vaccination coverage for the country | Annual |
| Estimated total dog population | Human population: urban, rural | A means to determine an estimated dog population for the country based on the HDR method ( | In most countries where rabies is endemic, there is no information about their current dog population; this lack of knowledge inhibits the assessment of the effectiveness of mass dog vaccination campaigns and also prevents countries from purchasing the correct number of doses of animal vaccine to achieve 70% coverage | Annual |
| Dog vaccination coverage | A means to determine the estimated vaccination coverage for the estimated dog population for the country | To enable decision makers to determine whether sufficient vaccine has been purchased and administered and for countries to plan ahead for vaccine purchase for the next year | Annual | |
| Animal rabies cases | Species: dog, cat, livestock, wildlife, bat | Determination of the number of suspect rabies cases submitted for laboratory confirmation. The results indicate the number of positive and negative cases per species, as well as the totals | Results to provide an indication of the effectiveness of a surveillance program by examining the positive:negative ratio | Biannual |
| Human rabies cases | Diagnosis: clinical, laboratory | The number of human rabies cases diagnosed clinically and by laboratory confirmation | To determine the burden of the disease and to determine the efficacy of disease intervention strategies | Biannual |
| Number of people receiving PEP | Sex: male; female; unknown | Number of humans receiving wound care and at least one dose of rabies vaccine for PEP | To determine the number of people receiving at least one dose of PEP in a country | Annual |
HDR, human:dog ratio; PEP, post-exposure prophylaxis.